Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Nephros (NEPH) over the last 16 years, with Q3 2025 value amounting to $621000.0.

  • Nephros' Change in Receivables rose 43208.56% to $621000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $970000.0, marking a year-over-year increase of 29591.84%. This contributed to the annual value of $285000.0 for FY2024, which is 2895.93% up from last year.
  • As of Q3 2025, Nephros' Change in Receivables stood at $621000.0, which was up 43208.56% from -$637000.0 recorded in Q2 2025.
  • Nephros' 5-year Change in Receivables high stood at $896000.0 for Q1 2025, and its period low was -$756000.0 during Q3 2022.
  • Moreover, its 5-year median value for Change in Receivables was $50000.0 (2023), whereas its average is $68789.5.
  • Its Change in Receivables has fluctuated over the past 5 years, first plummeted by 53953.49% in 2022, then skyrocketed by 397272.73% in 2025.
  • Quarter analysis of 5 years shows Nephros' Change in Receivables stood at $87000.0 in 2021, then tumbled by 201.15% to -$88000.0 in 2022, then skyrocketed by 156.82% to $50000.0 in 2023, then skyrocketed by 80.0% to $90000.0 in 2024, then skyrocketed by 590.0% to $621000.0 in 2025.
  • Its Change in Receivables was $621000.0 in Q3 2025, compared to -$637000.0 in Q2 2025 and $896000.0 in Q1 2025.